Search results with tag "Treatment of opioid"
Clinical Guidelines for the Use of Buprenorphine in the ...
www.beaconhealthoptions.comBuprenorphine in the Treatment of Opioid Addiction, provides consensus- and evidence-based guidance on the use of buprenorphine, a new option for the treatment of opioid addiction. The goal of this TIP is to provide information that physicians can use to make practical and informed decisions about the use of buprenorphine to treat opioid addiction.
Clinical guidelines for use of depot ... - NSW Health
www.health.nsw.gov.auClinical guidelines for use of depot buprenorphine (Buvidal® and Sublocade®) in the treatment of opioid dependence. ii NSW Health Use of depot BPN in the treatment of opioid dependence NSW Ministry of Health 100 Christie Street ST LEONARDS NSW 2065 Tel. (02) 9391 9000 Fax. (02) 9391 9101 TTY. (02) 9391 9900 www.health.nsw.gov.au ...
Ethical use of opioid treatment - WHO
www.who.int3 Our analysis of the practical application of these basic principles suggests that the ethical delivery of psychosocially-assisted treatment of opioid dependence treatment
NSW Clinical Guidelines: Treatment of Opioid …
www.health.nsw.gov.auNSW Health NSW Clinical Guidelines: Treatment of Opioid Dependence 5 Grading of recommendations Recommendations supported by research evidence are graded according to National Health and Medical Research Council (NHMRC) definitions, but with a 4-star rating system rather than letters.
Alcohol and Drug Withdrawal Clinical Practice Guidelines
adis.health.qld.gov.auThese guidelines have been adapted from the Drug and Alcohol Withdrawal Clinical Practice Guidelines – NSW with the kind permission of the Mental Health and Drug and Alcohol Office, New South Wales Ministry of Health. ... Australia for the treatment of opioid (heroin) withdrawal and maintenance. This is now
Integrated Service Delivery Models for Opioid Treatment ...
www.aatod.org1 Introduction This is the second of three policy papers that the American Association for the Treatment of Opioid Dependence (AATOD) has developed for the Substance Abuse and Mental Health
Brief Clinical guidelines for use of depot ... - NSW Health
www.health.nsw.gov.auNSW Health NSW Health Brief Clinical Guidelines for use of depot BPN in the treatment of opioid dependence 5 300mg doses should be considered for those patients who had previously stabilised on high dose SL BPN (e.g. 24 to 32mg daily), or continue
LAI BPN Clinical Guidelines - Queensland Health
www.health.qld.gov.auThese clinical guidelines have been developed with permission and based on Lintzeris N, Dunlop A, & Masters D (2019) Clinical guidelines for use of depot buprenorphine (Buvidal® and Sublocade®) in the treatment of opioid dependence. NSW Ministry of Health, Sydney Australia. Adaptions have been made
Guidelines for the Psychosocially Assisted Pharmacological ...
www.who.intiv Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence These guidelines were produced by the World Health Organization (WHO), Department of Mental Health and Substance Abuse, in collaboration with the
Similar queries
Buprenorphine, Treatment of Opioid, For the treatment of opioid, Opioid, Clinical guidelines, Ethical use of opioid treatment, Treatment, NSW Clinical Guidelines: Treatment of Opioid, NSW Clinical Guidelines: Treatment of Opioid Dependence, Drug Withdrawal Clinical Practice Guidelines, Guidelines, Withdrawal Clinical Practice Guidelines, New South Wales, Integrated Service Delivery Models for Opioid Treatment, Brief Clinical Guidelines for use of